Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
RESEARCH TOOLSreports
Kiniksa Pharmaceuticals (KNSA) Ownership Overview
7.91% Insiders
18.67% Mutual Funds
46.11% Other Institutional Investors
13.78% ETFs
13.53% Public Companies and Individual Investors
The ownership structure of Kiniksa Pharmaceuticals (KNSA) stock is a mix of institutional, retail, and individual investors. Approximately 78.56% of the company’s stock is owned by Institutional Investors, 7.91% is owned by Insiders, and 13.53% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,204,841 | Institution | 7.71% | 63,263,561 | |
| 3,001,877 | Institution | 7.22% | 59,257,052 | |
| 2,818,323 | Institution | 6.78% | 55,633,696 | |
| 2,760,099 | Insider | 6.64% | 54,484,354 | |
| 2,727,584 | Institution | 6.56% | 53,842,508 | |
| 1,573,768 | Institution | 3.79% | 31,066,180 | |
| 803,295 | Institution | 1.93% | 15,857,043 | |
| 695,294 | Institution | 1.67% | 13,725,104 | |
| 613,550 | Institution | 1.48% | 12,111,477 | |
| 604,400 | Institution | 1.45% | 11,930,856 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,727,584 | Institution | 6.56% | 53,842,508 | |
| 803,295 | Institution | 1.93% | 15,857,043 | |
| 695,294 | Institution | 1.67% | 13,725,104 | |
| 410,002 | Institution | 0.99% | 8,093,439 | |
| 392,276 | Institution | 0.94% | 7,743,528 | |
| 377,250 | Institution | 0.91% | 7,446,915 | |
| 311,881 | Institution | 0.75% | 6,156,531 | |
| 212,932 | Institution | 0.51% | 4,203,278 | |
| 122,749 | Institution | 0.30% | 2,423,065 | |
| 120,439 | Institution | 0.29% | 2,377,466 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,156,154 | Institution | 2.78% | 22,868,726 | |
| 1,029,969 | Institution | 2.48% | 20,331,588 | |
| 953,230 | Institution | 2.29% | 18,854,889 | |
| 538,250 | Institution | 1.29% | 10,646,585 | |
| 342,967 | Institution | 0.83% | 6,770,169 | |
| 182,210 | Institution | 0.44% | 3,604,114 | |
| 140,266 | Institution | 0.34% | 2,756,227 | |
| 140,266 | Institution | 0.34% | 2,756,227 | |
| 119,199 | Institution | 0.29% | 2,357,756 | |
| 102,914 | Institution | 0.25% | 2,022,260 |
FAQ
Who Owns Kiniksa Pharmaceuticals (KNSA)?
According to the latest TipRanks data, approximately 46.11% of the company's stock is held by institutional investors, 7.91% is held by insiders, and 13.53% is held by retail investors.
What percentage of Kiniksa Pharmaceuticals (KNSA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 46.11% of Kiniksa Pharmaceuticals (KNSA) stock is held by institutional investors.
What percentage of Kiniksa Pharmaceuticals (KNSA) stock is held by retail investors?
According to the latest TipRanks data, approximately 13.53% of Kiniksa Pharmaceuticals (KNSA) stock is held by retail investors.
Who owns the most shares of Kiniksa Pharmaceuticals (KNSA)?
Peter Harwin owns the most shares of Kiniksa Pharmaceuticals (KNSA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.